| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. | Cancer Res | 2009 | 3.18 |
| 2 | Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. | Blood | 2007 | 2.65 |
| 3 | Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. | J Immunol | 2010 | 1.38 |